Free Trial
LON:MXCT

MaxCyte (MXCT) Share Price, News & Analysis

MaxCyte logo
GBX 165.50 0.00 (0.00%)
As of 12:20 PM Eastern

About MaxCyte Stock (LON:MXCT)

Key Stats

Today's Range
161.80
170
50-Day Range
161.15
241
52-Week Range
160
407.84
Volume
15,706 shs
Average Volume
42,298 shs
Market Capitalization
£218.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions. Let’s Build Better Cells Together. To learn more, please visit www.maxcyte.com

Receive MXCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter.

MXCT Stock News Headlines

Shocking discovery could help you target payouts on weekends…
Since the pandemic, the average mortgage payment has jumped from $1,427 to $2,047. That's an extra $600 every single month just vanishing from people's pockets. Meanwhile, credit card debt is hitting record highs, and savings accounts are at their lowest since 2008. Most folks are left with two options… Get a second job... or work overtime on weekends. But what if there was a third option? I just uncovered a shocking anomaly in the options market that could change everything... One that lets you target extra cash on days when most people make nothing - weekends. Think what that could mean for your monthly budget...
6MXCT : A Look at MaxCyte's Upcoming...
MaxCyte to Propose AIM Delisting to Shareholders
MaxCyte (MXCT) Gets a Buy from BTIG
See More Headlines

MXCT Stock Analysis - Frequently Asked Questions

MaxCyte's stock was trading at GBX 321.20 at the beginning of the year. Since then, MXCT shares have decreased by 48.5% and is now trading at GBX 165.50.
View the best growth stocks for 2025 here
.

Shares of MXCT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that MaxCyte investors own include HSBC (HSBA), Royal Dutch Shell (RDSB), Cassava Sciences (SAVA), EQTEC (EQT), Grafton Group (GFTU), Lloyds Banking Group (LLOY) and Marks and Spencer Group (MKS).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
Business Services
Current Symbol
LON:MXCT
CIK
N/A
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£45.08 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£57.52 million
Cash Flow
GBX 83.92 per share
Price / Cash Flow
1.97
Book Value
GBX 203.85 per share
Price / Book
0.81

Miscellaneous

Free Float
N/A
Market Cap
£218.47 million
Optionable
Not Optionable
Beta
1.13
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (LON:MXCT) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners